Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
170M
-
Shares change
-
+10.9M
-
Total reported value, excl. options
-
$1.46B
-
Value change
-
+$87.8M
-
Put/Call ratio
-
0.2
-
Number of buys
-
88
-
Number of sells
-
-52
-
Price
-
$8.59
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q3 2019
181 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q3 2019.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 170M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (21.7M shares), BROWN CAPITAL MANAGEMENT LLC (17.9M shares), VANGUARD GROUP INC (16.7M shares), BlackRock Inc. (13.5M shares), FMR LLC (11.4M shares), UBS ASSET MANAGEMENT AMERICAS INC (10.7M shares), Sarissa Capital Management LP (10.1M shares), JANUS HENDERSON GROUP PLC (7.4M shares), MFN Partners Management, LP (6.44M shares), and STATE STREET CORP (5.83M shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.